Lamotrigine; 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine; 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine; BW 430C; LTG; Lamictal; Lamotrigin; 430C78; GI 267119X; 3,4-stage 2 isomer; Lamotrigine 430C78; 13W80 (Ph Eur Lamotrigine Impurity B); Lamotrigine stage 2 14W80 (Ph Eur Lamotrigine Impurity C)

名称与同义词

• lamotrigine
• Lamictal
• 84057-84-1
• Lamictal Cd
• Lamotrigina
• 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine
• Lamotriginum
• Lamictal XR
• Labileno
• Lamitor
• Lamictal ODT
• Lamictin
• Lamiktal
• Lamotriginum [Latin]
• Crisomet
• Lamotrigina [Spanish]
• lamitrin
• lamotrigin
• Lamotirigine
• Epilepax
• Lamotrigine-13C3
• Lamictal;
• Lamotrigine ER
• Lamotrigine CRS
• BW 430C
• Lamictal (TN)
• BW-430C
• SUBVENITE
• C9H7Cl2N5
• Lamictin (TN)
• LAMOTRIGINE Kit
• Opera_ID_12
• Lamotrigine (Standard)
• LAMOTRIGINE 1G
• LAMOTRIGINE 5G
• LTG;BW430C
• RefChem:5936
• BW430C
• Tocris-1611
• Lamotrigine-13C3,d3
• CHEMBL741
• DTXSID2023195
• MFCD00865333
• AC1L1GWT
• LAMOTRIGINE [MI]
• Lamotrigine [USAN:INN:BAN]
• 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
• LAMOTRIGINE [INN]
• LAMOTRIGINE [JAN]
• Lopac-L-3791
• Faes Brand of Lamotrigine
• PYZRQGJRPPTADH-UHFFFAOYSA-N
• LAMOTRIGINE [HSDB]
• LAMOTRIGINE [USAN]
• D03FLC
• Juste Brand of Lamotrigine
• lamotrigine extended-release
• UNII-U3H27498KS
• MLS000069685
• CHEBI:6367
• DTXCID203195
• Lamotrigine Extended Release
• Desitin Brand of Lamotrigine
• LAMOTRIGINE [MART.]
• U3H27498KS
• Lopac0_000688
• SCHEMBL35439
• LAMOTRIGINE [USP-RS]
• LAMOTRIGINE [WHO-DD]
• HSDB 7526
• MLS000759486
• MLS001077325
• MLS001423991
• BIDD:GT0794
• Lamotrigine (JAN/USP/INN)
• NSC-759171
• 3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine
• EINECS 281-901-8
• Lamotrigine-13C3,d3, Major
• Lamotrigine (JAN/USAN/INN)
• Lamotrigine [USAN:BAN:INN]
• lamotrigine chewable dispersible
• Lamotrigine, >=98%, powder
• 1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)-
• GTPL2622
• orb1310392
• TRI020
• C9-H7-Cl2-N5
• Lamotrigine, 1mg/ml in Ethanol
• EUR-1048
• Lamotrigine - Bio-X trade mark
• Lamotrigine [USAN:USP:INN:BAN]
• SCHEMBL29360953
• SCHEMBL29801510
• CTK8B4406
• ERK5-3B13
• HY-B0495R
• KS-00000XIV
• ZINC13156
• CID3878
• GW 273293
• LAMOTRIGINE [EP IMPURITY]
• LAMOTRIGINE [ORANGE BOOK]
• N03AX09
• s3024
• GLXC-07355
• HMS2051C10
• HMS2089M08
• HMS2093P21
• HMS2230L04
• HMS3262I17
• HMS3268G17
• HMS3371O16
• HMS3393C10
• HMS3657A17
• HMS3715H21
• HMS3885M03
• HMS5081I06
• LAMOTRIGINE [EP MONOGRAPH]
• LAMOTRIGINE [USP IMPURITY]
• Pharmakon1600-01505610
• LAMOTRIGINE [USP MONOGRAPH]
• AMY40805
• BCP12156
• CID:3878
• Glaxo Wellcome Brand of Lamotrigine
• HY-B0495
• Lamotrigine 1.0 mg/ml in Methanol
• MSK10267
• GlaxoSmithKline Brand of Lamotrigine
• Tox21_110179
• Tox21_500688
• ANW-44921
• BDBM50031299
• BW-430
• EBC-03614
• HB0368
• NCGC00015605-06
• NSC746307
• NSC759171
• STK628377
• SMR000058464
• AKOS005561147
• Lamotrigine for system suitability CRS
• Tox21_110179_1
• 6-(2,2,4-triazine-3,5-diyldiamine
• CCG-100856
• CS-2616
• DB00555
• GI 267119X
• ID58057
• KS-1074
• Lamotrigine for peak identification CRS
• LP00688
• NC00106
• NE61394
• NSC 746307
• NSC 759171
• NSC-746307
• SDCCGSBI-0050666.P003
• SMP2_000303
• NCGC00015605-01
• NCGC00015605-02
• NCGC00015605-03
• NCGC00015605-04
• NCGC00015605-05
• NCGC00015605-07
• NCGC00015605-08
• NCGC00015605-09
• NCGC00015605-10
• NCGC00015605-23
• NCGC00015605-24
• NCGC00022936-02
• NCGC00022936-04
• NCGC00022936-05
• NCGC00261373-01
• AC-10298
• AC-32483
• AJ-08354
• AK-72807
• AN-35947
• AT-15488
• BC200572
• BL166799
• BR-72807
• CPD000058464
• J25.814H
• K499
• SAM001246697
• SC-12025
• L 3791
• Lamotrigine 100 microg/mL in Acetonitrile
• SBI-0050666.P002
• SID:376229517
• AB0014255
• CAS-84057-84-1
• DB-014839
• LS-155249
• TR-026049
• B2249
• EU-0100688
• FT-0602546
• FT-0670713
• FT-0670714
• L-205
• L0241
• NS00000354
• ST24024203
• SW197486-3
• 57L841
• A11873
• D00354
• EN300-120680
• J10032
• W13018
• AB00384359-16
• AB00384359_17
• AB00384359_18
• A840709
• C047781
• F093440
• Q410346
• SR-01000000187
• 3,5-diamino-(2,3-dichlorophenyl)-1,2,4-triazine
• 3,5-diamino-6-(2,3-dichlorophenyl)- as -triazine
• 6-(2,3-Dichloro-phenyl)-[1,2,4]triazine-3,5-diamine
• Lamotrigine =98.0% (by HPLC, titration analysis)
• Lamotrigine for system suitability CRS (Y0001085)
• SR-01000000187-2
• SR-01000000187-4
• SR-01000000187-7
• (6M)-6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
• BRD-K93460210-001-22-9
• BRD-K93460210-001-23-7
• BRD-K93460210-071-01-6
• Lamotrigine for peak identification CRS (Y0001031)
• SR-01000000187-10
• 3,5-diamino-6-(2,3,-dichlorophenyl)-1,2,4-triazine
• 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine.
• D000077213
• F2173-0540
• Z1532338577
• 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diyldiamine
• B2692-078220
• Lamotrigine Working Standard (Secondary Reference Standard)
• Lamotrigine, British Pharmacopoeia (BP) Reference Standard
• Lamotrigine, European Pharmacopoeia (EP) Reference Standard
• 1,2,4-TRIAZINE-3,5-DIAMINE, 6-(2,3-DICHLOROPHENYL)
• 1188265-38-4
• 6-(2,3-Dichloro-phenyl)-[1,2,4]triazine-3,5-diamine(lamotrigine)
• GI 267119X; 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
• Lamotrigine, United States Pharmacopeia (USP) Reference Standard
• 1246815-13-3
• Lamotrigine, Pharmaceutical Secondary Standard; Certified Reference Material
• Lamotrigine for peak identification, European Pharmacopoeia (EP) Reference Standard
• Lamotrigine for system suitability, European Pharmacopoeia (EP) Reference Standard
• Lamotrigine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
• Lamotrigine, 98%, a novel anticonvulsant drug for inhibition of 5-HT - 1G 1g
• 281-901-8
• 658-035-8
• IYJ
• Lamotrigine; 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine; 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine; BW 430C; LTG; Lamictal; Lamotrigin; 430C78; GI 267119X; 3,4-stage 2 isomer; Lamotrigine 430C78; 13W80 (Ph Eur Lamotrigine Impurity B); Lamotrigine stage 2 14W80 (Ph Eur Lamotrigine Impurity C)
• LTg